Study in Malawi shows importance of screening HIV-positive patients for HBV co-infection and using tenofovir-containing regimens
Adding interferon to nucleoside antivirals may improve response for people with chronic hepatitis B
Hepatitis delta virus co-infection increases risk of poor liver-related outcomes for people living with HIV
Entecavir + tenofovir works well for people with hepatitis B who have had prior treatment failure
Hepatitis B treatment with entecavir or tenofovir lowers, but does not eliminate, liver cancer risk
Liver cancer often diagnosed late with poor survival in people with HIV
